Allan Vaag

Epigenetic differences arise during the lifetime of monozygotic twins

Mario F. Fraga, Esteban Ballestar, Maria F. Paz et al. · Proceedings of the National Academy of Sciences · 2005 · 3.6K citations · Full text

Medicine, Genetics, Molecular Genetics +16

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

Claus M. Larsen, Mirjam Faulenbach, Allan Vaag et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text

Medicine, Endocrinology, Pharmacology +17

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

David Russell‐Jones, Allan Vaag, O. Schmitz et al. · Diabetologia · 2009 · 829 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study

Pernille Poulsen, Kirsten Ohm Kyvik, Allan Vaag et al. · Diabetologia · 1999 · 618 citations · Full text

Life Sciences, Endocrinology, Genetics +9

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

Tina Ken Schramm, Gunnar Gislason, Lars Køber et al. · Circulation · 2008 · 541 citations

Medicine, Cardiology, Internal Medicine +12